Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer.

Name: Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer.
Author: Phillips, Roger M

Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer. — المؤلف: Phillips, Roger M — Cancer chemotherapy and pharmacology 20200303

المؤلف: Phillips, Roger M
النشر: Cancer chemotherapy and pharmacology 20200303
الوصف: 1183-1189 p.
الموضوعات: Antineoplastic Agents؛ Aziridines؛ Cell Line, Tumor؛ Chromatography, High Pressure Liquid؛ Half-Life؛ Hematuria؛ Humans؛ In Vitro Techniques